Dr. Rönsch received a double major in molecular medicine and political science at the Albert-Ludwigs University of Freiburg in Germany. During her undergraduate studies, she also attended University of British Columbia in Canada as a DAAD fellow. She went on to win a scholarship from the “Studienstiftung des Deutschen Volkes” for the support of her Ph.D. studies. In 2013, she obtained her doctoral degree in molecular medicine from the University of Freiburg. The focus of her Ph.D. thesis was on the molecular characterisation of tumour suppressor transcriptional inactivation during colorectal cancer progression. Dr. Rönsch continued her research as a post-doctoral fellow at the Karlsruhe Institute of Technology (KIT) where she investigated the molecular mechanisms of cancer metastasis. In 2015, Dr. Rönsch joined GATC Biotech’s R&D team. Her main responsibilities include the development of new panels for cancer research, as well as providing support to various Horizon2020 and other publicly funded projects.

Molecular characterisation of tumour suppressor